A phase III, multicenter, double-blind, randomized trial of celecoxib versus placebo in primary breast cancer patients: Randomized European Celecoxib Trial (REACT).
R. C. Coombes
Research Funding - Pfizer
G. Von Minckwitz
Research Funding - Pfizer
J. Hicks
No relevant relationships to disclose
P. Klare
No relevant relationships to disclose
A. A. Evans
Other Remuneration - Pfizer
M. Schmidt
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
A. Makris
No relevant relationships to disclose
R. Grieve
No relevant relationships to disclose
S. Loibl
No relevant relationships to disclose
L. Maher
No relevant relationships to disclose
K. Mousa
No relevant relationships to disclose
K. Buchsenscuhtz
No relevant relationships to disclose
R. A'Hern
No relevant relationships to disclose
J. M. Bliss
Research Funding - Pfizer